İrfan GÜNGÖR, Burcu AKBAŞ, Kadir KAYA, Hülya ÇELEBİ, UĞUR TAMER

Sudden developing convulsion during interscalene block: Does propofol anesthesia diminish plasma bupivacaine level?

Altmış yedi yaşında omuz rotator kaf yırtığı nedeniyle artroskopik omuz cerrahisi planlanan hastada interskalen blok uygulaması sırasında gelişen konvülziyon nedeniyle lokal anestezik sistemik toksisitesi (LAST) derlenmiştir.

İnterskalen blok sırasında ani gelişen konvülsiyon: Propofol anestezisi plazma bupivakain düzeyini azaltır mı?

Weaim to review local anesthetic systemic toxicity (LAST) due to suddenly developing convulsion during interscalene block in a 67 year old patient undergoing shoulder surgery.

PDF

___

1. Winnie AP. Interscalene brachial plexus block. Anesth Analg 1970;49(3):455-66.
2. Nishiyama T, Komatsu K. Local anesthetic toxic- ity in interscalene block: clinical series. Minerva Anestesiol 2010;76(12):1088-90.
3. Müller M, Litz RJ, Hüler M, Albrecht DM. Grand mal convul- sion and plasma concentrations after intravascular injection of ropivacaine for axillary brachial plexus blockade. Br J An- aesth 2001;87(5):784-7.
4. Ichikawa M, Ishiyama T, Shibuya K, Okawa I, Matsukawa T. Grand mal convulsion after an interscalene block with ropivacaine. [Article in Japanese] Masui 2009;58(4):467-9. [Ab- stract]
5. Gross AS, Nicolay A, Eschalier A. Simultaneous analysis of ketamine and bupivacaine in plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1999;728(1):107-15.
6. Misamore G, Webb B, McMurray S, Sallay P. A prospec- tive analysis of interscalene brachial plexus blocks per- formed under general anesthesia. J Shoulder Elbow Surg 2011;20(2):308-14.
7. Mulroy MF, Hejtmanek MR. Prevention of local anesthetic systemic toxicity. Reg Anesth Pain Med 2010;35(2):177-80.
8. Kiuchi MG, Zapata-Sudo G, Trachez MM, Ririe D, Sudo RT. The infuence of age on bupivacaine cardiotoxicity. Anesth Analg 2011;112(3):574-80.
9. Dhir S, Ganapathy S, Lindsay P, Athwal GS. Case report: ropi- vacaine neurotoxicity at clinical doses in interscalene bra- chial plexus block. Can J Anaesth 2007;54(11):912-6.
10. Auroy Y, Benhamou D, Bargues L, Ecofey C, Falissard B, Mer- cier FJ, et al. Major complications of regional anesthesia in France: The SOS Regional Anesthesia Hotline Service. Anes- thesiology 2002;97(5):1274-80.
11. Brown DL, Ransom DM, Hall JA, Leicht CH, Schroeder DR, Of- ford KP. Regional anesthesia and local anesthetic-induced systemic toxicity: seizure frequency and accompanying car- diovascular changes. Anesth Analg 1995;81(2):321-8.
12. Satsumae T, Tanaka M, Saito S, Inomata S. Convulsions after ropivacaine 300 mg for brachial plexus block. Br J Anaesth 2008;101(6):860-2.
13. Crews JC, Rothman TE. Seizure after levobupivacaine for interscalene brachial plexus block. Anesth Analg 2003;96(4):1188-90.
14. Groban L. Central nervous system and cardiac efects from long-acting amide local anesthetic toxicity in the intact ani- mal model. Reg Anesth Pain Med 2003;28(1):3-11.
15. Denson DD, Myers JA, Hartrick CT, Pither CP, Coyle DE, Raj PP. The relationship between free bupivacaine concentra- tion and central nervous system toxicity. Anesthesiology 1984;61:A211.
16. Tucker GT, Mather LE. Clinical pharmacokinetics of local an- aesthetics. Clin Pharmacokinet 1979;4(4):241-78.
17. de Jong RH, Ronfeld RA, DeRosa RA. Cardiovascular efects of convulsant and supraconvulsant doses of amide local anes- thetics. Anesth Analg 1982;61(1):3-9.
18. Knudsen K, Beckman Suurküla M, Blomberg S, Sjövall J, Ed- vardsson N. Central nervous and cardiovascular efects of i.v. infusions of ropivacaine, bupivacaine and placebo in volun- teers. Br J Anaesth 1997;78(5):507-14.
19. Weinberg GL. Current concepts in resuscitation of patients with local anesthetic cardiac toxicity. Reg Anesth Pain Med 2002;27(6):568-75.
20. Turner-Lawrence DE, Kerns Ii W. Intravenous fat emulsion: a potential novel antidote. J Med Toxicol 2008;4(2):109-14.
21. Ozcan MS, Weinberg G. Update on the use of lipid emulsions in local anesthetic systemic toxicity: a focus on diferential efcacy and lipid emulsion as part of advanced cardiac life support. Int Anesthesiol Clin 2011;49(4):91-103.
22. Neal JM, Bernards CM, Butterworth JF 4th, Di Gregorio G, Drasner K, Hejtmanek MR, et al. ASRA practice advisory on local anesthetic systemic toxicity. Reg Anesth Pain Med 2010;35(2):152-61.
23. Weinberg GL, VadeBoncouer T, Ramaraju GA, Garcia-Amaro MF, Cwik MJ. Pretreatment or resuscitation with a lipid infu- sion shifts the dose-response to bupivacaine-induced asys- tole in rats. Anesthesiology 1998;88(4):1071-5.
24. Ohmura S, Ohta T, Yamamoto K, Kobayashi T. A comparison of the efects of propofol and sevofurane on the systemic toxicity of intravenous bupivacaine in rats. Anesth Analg 1999;88(1):155-9.
25. Yılmaz M, Çelebi H, Akcali D, Gurel N. Pretreatment with dif- ferent lipid formulations of propofol for bupivacaine indused cardiotoxicity. 30th Annual ESRA Congress 2011, Dresden, Germany, Free Communications, September 7-10, 2011; pp. 15.
26. Bishop D, Johnstone RE. Lidocaine toxicity treated with low- dose propofol. Anesthesiology 1993;78(4):788-9.
27. Büttner J, Meier G. Pharmakologie und Toxikologie der Lo- kalanästhetika. In: Kontunuierliche periphere Techniken zur Regionalanästhesie und Schmerztherapie-Obere und untere Extremität. Uni-MED Bremen. 1. Aufage, 1999;27.